TITLE

HP and Irish company begin drug-delivery collaboration

PUB. DATE
September 2007
SOURCE
Medical Device Daily;9/26/2007, Vol. 11 Issue 184, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the decision of HP and medical device developer Crospon to enter into a licensing agreement for a drug-delivery platform that enables painless, controlled release of one or more drugs in a single patch applied to the skin. The agreements calls for HP to license its intellectual property to Crospon in return for royalty payments.
ACCESSION #
26766781

 

Related Articles

  • UConn lagging in licensing income. Soule, Alexander // Fairfield County Business Journal;1/21/2008, Vol. 47 Issue 3, p5 

    The article reports that the University of Connecticut (UConn) lags behind in licensing income. The researchers from UConn announces the development of microscopic chips that can monitor the health of soldiers. According to the Association of University Technology Managers (AUTM), UConn has...

  • Numbers.  // InsideCounsel;Sep2015, Vol. 26 Issue 283, p31 

    The article discusses statistical developments in the corporate intellectual property (IP) sector. Topics covered include a PricewaterhouseCoopers research showing 81 percent of respondents find reasonable royalties as the most frequent type of legal damage rewarded in patent lawsuit cases, and...

  • INTELLECTUAL ARGUMENT. CORNER, CHRISTINE // Accountancy;Sep2011, Vol. 148 Issue 1417, p68 

    The article highlights the importance of royalty audits for intellectual property (IP) rights-holding companies in Great Britain. It reports on the growing importance of royalties as a source of revenue across a whole range of industries, including film, television and music publishing. It lists...

  • royalty. Stim, Richard // Contracts: The Essential Business Desk Reference;2010, p409 

    A definition of the term "royalty" is presented. It refers to a periodic payment for the sale or license of a product or service. An inventor, for instance, may license his idea to a company that uses it to create a product, in exchange for a yearly royalty based on sales of the product. A...

  • Deals roundup.  // Medical Device Daily;11/25/2008, Vol. 12 Issue 230, p9 

    The article announces that Covidien has licensed worldwide rights from Depomed to utilize its AcuForm gastric retentive drug delivery technology for the exclusive development of four undisclosed products. According to Covidien, these products will focus on its pharmaceutical business and address...

  • Three-Step Analysis to Manage the 'Noise' in IP Royalty Rate Data.  // Business Valuation Update;May2014, Vol. 20 Issue 5, p1 

    The article looks at suggested ways for valuation analysts to reduce divergent data when calculating intellectual property royalty rate. Topics mentioned include use of commercial databases to find royalty rate data and license agreements, advice on eliminating data that do not fit the subject...

  • Licensing Intellectual Property With Self-Reported Outcomes. Autrey, Romana L.; Sansing, Richard // Journal of Accounting, Auditing & Finance;Jul2014, Vol. 29 Issue 3, p260 

    The licensing of intellectual property (IP) is growing dramatically. A distinguishing feature of licensing versus standard sales is that license contracts often involve self-reporting; the licensor relies on the licensee to report the royalties owed. This study examines self-reporting licensing...

  • How's your IP portfolio?  // NZ Business;Mar2008, Vol. 22 Issue 2, p64 

    The article focuses on the importance of intellectual property (IP) portfolio to small business owners in New Zealand. Mark Lowndes, a partner at Lowndes Associates, emphasizes that a good IP portfolio should allow licensing and protection of ideas, including the generation of royalties. IP...

  • ROYALTÄ° VE LÄ°SANS ÖDEMELERÄ°NÄ°N GÃœMRÃœK Ä°DARESÄ°NE BEYANI VE VERGÄ°LENDÄ°RÄ°LMESÄ° NASIL OLMALIDIR. BOZKURT, Nevzat // Mali Cozum Dergisi / Financial Analysis;2011, Issue 104, p121 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics